Shanghai Pharmaceuticals Holding Co Ltd (601607) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shanghai Pharmaceuticals Holding Co Ltd (601607) has a cash flow conversion efficiency ratio of 0.017x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥1.56 Billion ≈ $227.99 Million USD) by net assets (CN¥89.62 Billion ≈ $13.11 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 601607 stock market capitalisation for the company's overall valuation and market capitalisation.
Shanghai Pharmaceuticals Holding Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)
This chart illustrates how Shanghai Pharmaceuticals Holding Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Shanghai Pharmaceuticals Holding Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shanghai Pharmaceuticals Holding Co Ltd ranked by their cash flow conversion efficiency. Explore 601607 operating cash flow to net income to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bank of Maharashtra
NSE:MAHABANK
|
-0.678x |
|
Schaeffler India Limited
NSE:SCHAEFFLER
|
0.094x |
|
99 Speed Mart Retail Holdings Berhad
KLSE:5326
|
0.085x |
|
KION GROUP AG ADRS/1/4
F:KGX1
|
0.037x |
|
CSN Mineração S.A
SA:CMIN3
|
0.096x |
|
Prestige Estates Projects Limited
NSE:PRESTIGE
|
0.113x |
|
JCHX Mining Management Co Ltd
SHG:603979
|
0.084x |
|
Albertsons Companies
NYSE:ACI
|
0.659x |
Annual Cash Flow Conversion Efficiency for Shanghai Pharmaceuticals Holding Co Ltd (1998–2025)
The table below shows the annual cash flow conversion efficiency of Shanghai Pharmaceuticals Holding Co Ltd from 1998 to 2025. View current stock price of Shanghai Pharmaceuticals Holding Co Ltd for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥89.79 Billion ≈ $13.14 Billion |
CN¥6.15 Billion ≈ $900.55 Million |
0.069x | -1.50% |
| 2024-12-31 | CN¥83.74 Billion ≈ $12.25 Billion |
CN¥5.83 Billion ≈ $852.71 Million |
0.070x | +6.84% |
| 2023-12-31 | CN¥80.33 Billion ≈ $11.75 Billion |
CN¥5.23 Billion ≈ $765.54 Million |
0.065x | +7.10% |
| 2022-12-31 | CN¥78.00 Billion ≈ $11.41 Billion |
CN¥4.74 Billion ≈ $694.10 Million |
0.061x | -29.03% |
| 2021-12-31 | CN¥59.07 Billion ≈ $8.64 Billion |
CN¥5.06 Billion ≈ $740.63 Million |
0.086x | -31.47% |
| 2020-12-31 | CN¥54.74 Billion ≈ $8.01 Billion |
CN¥6.84 Billion ≈ $1.00 Billion |
0.125x | +2.54% |
| 2019-12-31 | CN¥49.39 Billion ≈ $7.23 Billion |
CN¥6.02 Billion ≈ $881.26 Million |
0.122x | +80.61% |
| 2018-12-31 | CN¥46.43 Billion ≈ $6.79 Billion |
CN¥3.14 Billion ≈ $458.77 Million |
0.068x | +1.13% |
| 2017-12-31 | CN¥39.68 Billion ≈ $5.81 Billion |
CN¥2.65 Billion ≈ $387.60 Million |
0.067x | +26.32% |
| 2016-12-31 | CN¥36.83 Billion ≈ $5.39 Billion |
CN¥1.95 Billion ≈ $284.86 Million |
0.053x | +32.43% |
| 2015-12-31 | CN¥33.81 Billion ≈ $4.95 Billion |
CN¥1.35 Billion ≈ $197.42 Million |
0.040x | -7.08% |
| 2014-12-31 | CN¥31.10 Billion ≈ $4.55 Billion |
CN¥1.34 Billion ≈ $195.45 Million |
0.043x | +27.95% |
| 2013-12-31 | CN¥29.00 Billion ≈ $4.24 Billion |
CN¥973.45 Million ≈ $142.45 Million |
0.034x | -19.20% |
| 2012-12-31 | CN¥27.70 Billion ≈ $4.05 Billion |
CN¥1.15 Billion ≈ $168.39 Million |
0.042x | -39.10% |
| 2011-12-31 | CN¥25.98 Billion ≈ $3.80 Billion |
CN¥1.77 Billion ≈ $259.36 Million |
0.068x | -51.92% |
| 2010-12-31 | CN¥11.88 Billion ≈ $1.74 Billion |
CN¥1.69 Billion ≈ $246.73 Million |
0.142x | -50.39% |
| 2009-12-31 | CN¥2.32 Billion ≈ $339.84 Million |
CN¥664.13 Million ≈ $97.18 Million |
0.286x | +109.19% |
| 2008-12-31 | CN¥2.09 Billion ≈ $305.80 Million |
CN¥285.68 Million ≈ $41.80 Million |
0.137x | -45.25% |
| 2007-12-31 | CN¥1.96 Billion ≈ $286.56 Million |
CN¥488.94 Million ≈ $71.55 Million |
0.250x | -11.50% |
| 2006-12-31 | CN¥2.07 Billion ≈ $302.45 Million |
CN¥583.11 Million ≈ $85.33 Million |
0.282x | +675.17% |
| 2005-12-31 | CN¥2.01 Billion ≈ $293.52 Million |
CN¥73.00 Million ≈ $10.68 Million |
0.036x | +21.65% |
| 2004-12-31 | CN¥2.06 Billion ≈ $301.60 Million |
CN¥61.66 Million ≈ $9.02 Million |
0.030x | +13043.04% |
| 2003-12-31 | CN¥2.13 Billion ≈ $311.31 Million |
CN¥484.27K ≈ $70.86K |
0.000x | -99.55% |
| 2002-12-31 | CN¥2.00 Billion ≈ $292.60 Million |
CN¥100.84 Million ≈ $14.76 Million |
0.050x | +39.50% |
| 2001-12-31 | CN¥1.82 Billion ≈ $266.06 Million |
CN¥65.73 Million ≈ $9.62 Million |
0.036x | -75.64% |
| 2000-12-31 | CN¥985.30 Million ≈ $144.18 Million |
CN¥146.22 Million ≈ $21.40 Million |
0.148x | -23.41% |
| 1999-12-31 | CN¥849.92 Million ≈ $124.37 Million |
CN¥164.67 Million ≈ $24.10 Million |
0.194x | +148.82% |
| 1998-12-31 | CN¥713.42 Million ≈ $104.40 Million |
CN¥-283.14 Million ≈ $-41.43 Million |
-0.397x | -- |
About Shanghai Pharmaceuticals Holding Co Ltd
Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric … Read more